NIH employee placed on leave after openly criticizing Trump

In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook

Anthony G. Letai’s initiation as the 18th director of the National Cancer Institute wasn’t exactly smooth.

December 05, 2025

FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies

FDA issued a draft guidance on Dec. 2, outlining specific product types for which the FDA believes six-month non-human primate toxicity testing can be eliminated or reduced.

UAMS receives $10.5M NIH grant to develop biomarkers through proteomics

The University of Arkansas for Medical Sciences received a $10.5 million NIH grant to develop biomarkers for all human diseases, including cancer, through proteomics.

December 05, 2025

Vol.51 No.44

Cancer Policy

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

Approximately one in 30 NIH-funded clinical trials—and more than 74,000 trial participants—were affected by grant funding disruptions caused by the Trump administration, according to an analysis in JAMA Internal Medicine.

Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer

Natalie Phelps, a 43-year-old mother of two, died Nov. 9 from colorectal cancer.

November 21, 2025

Vol.51 No.43

By Claire Marie Porter and Jacquelyn Cobb

In Brief

Kate Klimczak appointed president of ACT for NIH, Richard Turman steps down

Kate KlimczakRichard TurmanRichard Turman announced that he will be stepping down from leadingAct for NIH, an NIH advocacy organization, and its affiliated education arm ACT for NIH Foundation, effective Jan. 1, 2026.

November 21, 2025

Vol.51 No.43

NIH employee placed on leave after openly criticizing Trump

YOU MAY BE INTERESTED IN

In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook

FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies

UAMS receives $10.5M NIH grant to develop biomarkers through proteomics

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer

Kate Klimczak appointed president of ACT for NIH, Richard Turman steps down

Renew today!

Subscriber content

Never miss an issue!

Login